press

Carlsbad, California (April 11, 2023) - RCE Technologies, Inc. Heart disease is a leading cause of death worldwide, and heart attacks are a particularly dangerous form of heart disease. When

Torrey Pines, California (March 25, 2023) The 17th Annual Biomarkers and Personalized Medicine in Cardiovascular Disease Symposium showcased the latest clinical data, guidelines and evidence related to the clinical application

New Orleans, LA (March 6, 2023) - RCE Technologies, Inc's groundbreaking study titled "A Novel Breakthrough In Wrist-Worn Transdermal Troponin-I-Sensor Assessment For Acute Myocardial Infarction" was presented at the American

Carlsbad, California (March 2, 2023) - RCE Technologies, Inc. has just announced a major addition to the clinical team: the highly acclaimed Ronald P. Karlsberg, MD, FACC. As a Clinical

Carlsbad, California (December 20, 2022) - RCE Technologies, Inc. has been accepted to present at the American College of Cardiology - Late Breaking Clinical Trials. The presentation titled, "A Novel

September 14, 2022 | New Brunswick, NJ With rapid transformation of cardiovascular medicine from reactive to preventive, the Rutgers Robert Wood Johnson University Hospital is investing in the vision of a

Feburary 22, 2022 | Carlsbad, CA RCE, the AI med tech company developing point of care Troponin diagnostics, has announced the award of its first patent from the U. S. Patent

RCE is 1 of 7 companies selected from around the world into TMCx Fall 2020 cohort.

Georgia Bio announces RCE as the winner of its 2020 GaBio Summit Pitch Rounds competition.

RCE is excited to join the Advanced Technology Development Center (ATDC) accelerate program, Georgia Tech's startup incubator

RCE wins the 2019 SEMDA PitchRounds competition and works towards bringing a valuable diagnostic solution to market